Article Text

PDF
Acute coronary syndromes
Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction
  1. John F Younger1,2,
  2. Sven Plein1,2,
  3. Julian Barth3,
  4. John P Ridgway1,4,
  5. Stephen G Ball1,2,
  6. John P Greenwood1,2
  1. 1
    Cardiac Magnetic Resonance Unit, Leeds General Infirmary, Leeds, UK
  2. 2
    Academic Unit of Cardiovascular Medicine, University of Leeds, Leeds, UK
  3. 3
    Department of Clinical Biochemistry, Leeds General Infirmary, Leeds, UK
  4. 4
    Department of Medical Physics, Leeds General Infirmary, Leeds, UK
  1. Dr J Greenwood, Senior Lecturer in Cardiology, Academic Unit of Cardiovascular Medicine, G Floor, Jubilee Wing, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK; j.greenwood{at}leeds.ac.uk

Abstract

Objectives: The aim of this study was to use late gadolinium hyper-enhancement cardiac magnetic resonance (LGE-CMR) imaging to determine if a 72-h troponin-I measurement would provide a more accurate estimation of infarct size and microvascular obstruction (MVO) than serial creatine kinase (CK) or early troponin-I values.

Methods: LGE-CMR was performed 3.7±1.4 days after medical treatment for acute ST elevation or non-ST elevation myocardial infarction. Infarct size and MVO were measured and correlated with serum troponin-I concentrations, which were sampled 12 h and 72 h after admission, in addition to serial CK levels.

Results: Ninety-three patients, of whom 71 had received thrombolysis for ST elevation myocardial infarction, completed the CMR study. Peak CK, 12-h troponin-I, and 72-h troponin-I were related to infarct size by LGE-CMR (r = 0.75, p<0.0001; r = 0.56, p = 0.0003; r = 0.62, p<0.0001 respectively). Serum biomarkers demonstrated higher values in the group with MVO compared with those without MVO (Peak CK 3085±1531 vs 1471±1135, p<0.001; 12-h troponin-I 58.3±46.9 vs 33.4±40.0, p = 0.13; 72-h troponin-I 11.5±9.9 vs 5.5±4.6, p<0.005). The correlation between the extent of MVO and 12-h troponin-I was not significant (r = 0.16), in contrast to the other serum biomarkers (peak CK r = 0.44, p<0.0001; 72-h troponin-I r = 0.46, p = 0.0002).

Conclusion: A single measurement of 72-h troponin-I is similar to serial CK measurements in the estimation of both myocardial infarct size and extent of MVO, and is superior to 12-h troponin-I measurements.

Statistics from Altmetric.com

Footnotes

  • Funding: Dr Younger and Professor Ball are supported by the British Heart Foundation. Dr Plein is supported by the Wellcome Trust.

  • Competing interests: None.

  • Abbreviations:
    AMI
    acute myocardial infarction
    CK
    creatine kinase
    LGE-CMR
    late gadolinium hyper-enhancement cardiac magnetic resonance
    LV
    left ventricular
    MVO
    microvascular obstruction
    NSTEMI
    non-ST elevation myocardial infarction
    PCI
    percutaneous coronary intervention
    STEMI
    ST elevation myocardial infarction

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.